Meg Jardine's Publications

About Meg Jardine's Publications

Honorary Professorial Fellow, The George Institute for Global Health
  • Associate Professor, Faculty of Medicine, UNSW Sydney

  • Glucose lowering and the kidney: are all drug classes equal?

    The Lancet Diabetes & Endocrinology Date published:

  • Cardiovascular and Renal Outcomes With Canagliflozin According to Baseline Kidney Function

    Circulation Date published:

  • Canagliflozin and Cardiovascular (CV) Outcomes in Patients with Chronic Kidney Disease

    Diabetes Date published:

  • Cardiovascular Outcomes Reported in Hemodialysis Trials

    Journal of the American College of Cardiology Date published:

  • Renal trials in diabetes need a platform: time for a global approach?

    The Lancet Diabetes & Endocrinology Date published:

  • FP513CARDIOVASCULAR EVENTS IN A LINKED DATA COHORT OF DIALYSIS PATIENTS: IMPACT OF MODALITY AND EVENT DEFINITION

    Nephrology Dialysis Transplantation Date published:

  • SP243PROGNOSTIC SIGNIFICANCE OF LOW LEVEL OF BLOOD GLUCOSE IN SEVERE ACUTE KIDNEY INJURY: A SECONDARY ANALYSIS FROM THE RENAL STUDY

    Nephrology Dialysis Transplantation Date published:

  • Design and methods of the REMOVAL-HD study: a tRial Evaluating Mid cut-Off Value membrane clearance of Albumin and Light chains in HaemoDialysis patients

    BMC Nephrology Date published:

  • Exploring the Clinical Relevance of Providing Increased Removal of Large Middle Molecules

    Clinical Journal of the American Society of Nephrology Date published:

  • CAUSE OF DEATH VARIES ACROSS AUSTRALIA, NEW ZEALAND AND MALAYSIA IN THOSE ON RENAL REPLACEMENT THERAPY - RESULTS FROM THE STUDY OF HEART AND RENAL PROTECTION-EXTENDED REVIEW (SHARP-ER)

    Date published:

  • ASSESSING BASELINE MEDICATION USE IN CHRONIC KIDNEY DISEASE: AN ANALYSIS OF THE SHARP-ER STUDY

    Date published:

  • PROGNOSTIC SIGNIFICANCE OF LOW LEVEL OF BLOOD GLUCOSE IN SEVERE ACUTE KIDNEY INJURY: A SECONDARY ANALYSIS FROM THE RENAL STUDY

    Date published:

  • Canagliflozin and cardiovascular outcomes in patients with chronic kidney disease

    Date published:

  • The Canagliflozin and Renal Endpoints in Diabetes with Established Nephropathy Clinical Evaluation (CREDENCE) Study Rationale, Design, and Baseline Characteristics

    American Journal of Nephrology Date published:

  • Erythropoietic response to oral iron in patients with nondialysis-dependent chronic kidney disease in the FIND-CKD trial

    Clinical Nephrology Date published:

  • Action plan for optimizing the design of clinical trials in chronic kidney disease

    Kidney International Supplements Date published: